Upadacitinib beats placebo for psoriatic arthritis
For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J
Updated on: May 26,2024
8

Upadacitinib beats placebo for psoriatic arthritis
For patients with psoriatic arthritis, upadacitinib at a dose of 15 mg or 30 mg once daily is more effective than placebo, according to a study published in the April 1 issue of theNew England J
Updated on:May 26,2024
8
